Saladax Biomedical, Inc. - Product Pipeline Analysis, 2015 Update : Global Market Size, Growth, Shares And Forecast Research Report

Summary:

Saladax Biomedical, Inc. (Saladax) is a diagnostic company that develops and offers diagnostic tests for the delivery of medicine in oncology. The company's products include My5-FU, MyPaclitaxel and MyDocetaxel. Saladax’s My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracilMyPaclitaxel is blood test used to measure exposure of patient to paclitaxeland MyDocetaxel measures patient’s exposure to docetaxel. Its products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. The company offers products through a network of distributors in the US and around the world. Saladax is headquartered in Bethlehem, Pennsylvania, the US.


This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Saladax Biomedical, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948

Comments

Popular posts from this blog

Global Organic Drinks Industrial Trend and Market Demand 2016-2020

Global Night Vision Devices Industrial Trend and Market Demand 2016-2020

Global Handling and Lifting Equipment Industrial Trend and Market Demand 2016-2020